Mosaic HIV-1 vaccination induces anti-viral CD8+ T cell functionality in the phase 1/2a clinical trial APPROACH

J van Duijn, D Stieh, N Fernandez, D King… - Journal of …, 2023 - Am Soc Microbiol
… of anti-viral T cells that show broad cross-reactivity across … /IL2 expansion results in
activation of CD8+ T cells. Washing … -1 vaccine regimens that were designed to elicit HIV-1-specific

[HTML][HTML] T cell receptor–targeted immunotherapeutics drive selective in vivo HIV-and CMV-specific T cell expansion in humanized mice

M Li, SJ Garforth, KE O'Connor, H Su… - The Journal of …, 2021 - Am Soc Clin Investig
… expanding highly functional virus-specific cytotoxic CD8 + T cells, … of TCR signal alone was
sufficient to drive proliferation of … treatment is that in contrast to broadly antigenic HIV vaccines

[HTML][HTML] Antigen-driven clonal selection shapes the persistence of HIV-1–infected CD4+ T cells in vivo

FR Simonetti, H Zhang, GP Soroosh… - The Journal of …, 2021 - Am Soc Clin Investig
… evidence for antigen-driven clonal expansion in vivo and … T cell responses are broad and
heterogeneous (38, 39), we … To study HIV-1specific cells, we used overlapping Gag peptides, …

[HTML][HTML] Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8+ T cells

…, D Suttichom, P Prueksakaew, T Chalermchai… - …, 2022 - thelancet.com
… status and function of HIV-specific CD8 + T cells after long-term ART … CD8 + T cells with
high expansion (P<0·0008) and cytotoxic capacity (P=0·02) after in vitro recall, albeit at low cell

[HTML][HTML] Virtual memory CD8+ T cells restrain the viral reservoir in HIV-1-infected patients with antiretroviral therapy through derepressing KIR-mediated inhibition

JH Jin, HH Huang, MJ Zhou, J Li, W Hu… - Cellular & Molecular …, 2020 - nature.com
CD8+ T cell expansion is a common feature of HIV-1 infection… of functional markers in T VM
cells and total CD8+ T cells (Fig… , which enables a broad TCR repertoire and strong immune …

[HTML][HTML] Engaging innate immunity in HIV-1 cure strategies

NL Board, M Moskovljevic, F Wu, RF Siliciano… - Nature Reviews …, 2022 - nature.com
… Latently infected cells can persist through clonal expansion … with a therapeutic vaccine to
strengthen HIV-1-specific T cell … , for example given the far broader effects of TLR8 agonists on …

[HTML][HTML] CD8+ T-cell responses in HIV controllers: Potential implications for novel HIV remission strategies

RL Rutishauser, L Trautmann - Current Opinion in HIV and AIDS, 2022 - ncbi.nlm.nih.gov
… , broadly cross-reactive T cell receptors and epitope targeting, enhanced expansion and
antiviral … with a therapeutic vaccine plus PD-1 blockade demonstrated improved and sustained …

[HTML][HTML] Conserved multiepitope vaccine constructs: A potent HIV-1 therapeutic vaccine in clinical trials

E Akbari, M Seyedinkhorasani, A Bolhassani - The Brazilian Journal of …, 2023 - Elsevier
… It can induce effective HIV-1-specific immunity to control … regions containing a wide range
of critical T- and B-cell epitopes of … -1 genome can activate Cytotoxic T Lymphocytes (CTLs) in …

Host immunity associated with spontaneous suppression of viremia in therapy-naïve young rhesus macaques following neonatal SHIV infection

…, ES Geanes, N De Naeyer, T DeMarco… - Journal of …, 2023 - Am Soc Microbiol
… are children, and a protective vaccine or cure is needed to end … potential to develop breadth
as broadly reactive nAbs (bnAbs) … Robust HIV-1-specific CD4 and CD8 T cells were recently …

Viral T-cell epitopes–Identification, characterization and clinical application

SM Schroeder, A Nelde, JS Walz - Seminars in Immunology, 2023 - Elsevier
… such as the TCR sequencing-based assays become broadly … Although HIV-1-specific T-cell
responses were demonstrated … of virus-specific T cells after vaccination requires some time …